National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Breast Cancer Screening (PDQ®)
Patient Version   Health Professional Version   Last Modified: 08/26/2008
Table 2. Harms of Screening Clinical Breast Examination

Harms  Study Design  Internal Validity  Consistency  Magnitude of Effects  External Validity 
Additional testing (false-positives) Descriptive population-based Good Good Specificity in women aged 50 to 59 years ranged between 88% and 96%.[13] Good
False reassurance, delay in cancer diagnosis (false-negatives) Descriptive population-based Good Fair Of women with cancer, 17% to 43% had a negative clinical breast examination.[13] Poor

References

  1. Baines CJ, Miller AB, Bassett AA: Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study. Cancer 63 (9): 1816-22, 1989.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov